Literature DB >> 21553326

Renal FMD may not confer a familial hypertensive risk nor is it caused by ACTA2 mutations.

Stephen D Marks1, Ambrose M Gullett, Eileen Brennan, Kjell Tullus, Graciana Jaureguiberry, Enriko Klootwijk, Horia C Stanescu, Robert Kleta, Adrian S Woolf.   

Abstract

Renal fibromuscular dysplasia (FMD) can cause hypertension, and previous reports suggest that FMD is familial. We hypothesized that, in families containing an individual with proven FMD, relatives of index cases would have an increased risk of hypertension. ACTA2 mutations cause a spectrum of extra-renal arteriopathy, leading to our second hypothesis that mutations are implicated in FMD. The blood pressure of first-degree relatives was measured using standard devices and, when indicated, with 24-h ambulatory monitoring. Leucocyte DNA was obtained from FMD index cases and ACTA2 sequenced. Thirteen unrelated index cases, aged 2-32 (median 15) years, were recruited. Blood pressure was assessed in 40 first-degree relatives, comprising 22 parents aged 28-58 (median 44) years and 18 siblings aged 3-30 (median 13) years. Hypertension was evident in six (27%) parents but in none of the eight adult siblings. Of the ten screened siblings aged less than 18 years, one teenager was pre-hypertensive (90th-95th centile), the remainder being normotensive. No ACTA2 mutations were found in 13 index cases. Hypertension was evident in 20% of all assessed adult first-degree relatives and is therefore not increased relative to 25% of the adult population. Although hypertensive parents did not undergo angiography to assign FMD status, this observation, together with the lack of hypertension in 18 siblings, indicates that FMD is unlikely to confer an excess hypertension risk in first-degree relatives up to middle-age. Furthermore, in our cohort, FMD was not caused by ACTA2 mutations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21553326     DOI: 10.1007/s00467-011-1891-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  21 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  Angiopoietin-2 is a site-specific factor in differentiation of mouse renal vasculature.

Authors:  Hai Tao Yuan; Chitra Suri; David N Landon; George D Yancopoulos; Adrian S Woolf
Journal:  J Am Soc Nephrol       Date:  2000-06       Impact factor: 10.121

3.  Angioplasty for renovascular hypertension in children: 20-year experience.

Authors:  Rukshana Shroff; Derek J Roebuck; Isky Gordon; Roger Davies; Suzanne Stephens; Stephen Marks; Mark Chan; Maria Barkovics; Clare A McLaren; Vanita Shah; Michael J Dillon; Kjell Tullus
Journal:  Pediatrics       Date:  2006-07       Impact factor: 7.124

4.  Incidental fibromuscular dysplasia in potential renal donors: long-term clinical follow-up.

Authors:  A H Cragg; T P Smith; B H Thompson; T P Maroney; A W Stanson; G T Shaw; D W Hunter; S T Cochran
Journal:  Radiology       Date:  1989-07       Impact factor: 11.105

5.  Results of surgical treatment for renovascular hypertension in children: 30 year single centre experience.

Authors:  Marike B Stadermann; Giovanni Montini; George Hamilton; Derek J Roebuck; Clare A McLaren; Michael J Dillon; Stephen D Marks; Kjell Tullus
Journal:  Nephrol Dial Transplant       Date:  2009-10-21       Impact factor: 5.992

Review 6.  Renovascular hypertension in children.

Authors:  Kjell Tullus; Eileen Brennan; George Hamilton; Rozanne Lord; Clare A McLaren; Stephen D Marks; Derek J Roebuck
Journal:  Lancet       Date:  2008-04-26       Impact factor: 79.321

7.  Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder.

Authors:  Robert Kleta; Elisa Romeo; Zorica Ristic; Toshihiro Ohura; Caroline Stuart; Mauricio Arcos-Burgos; Mital H Dave; Carsten A Wagner; Simone R M Camargo; Sumiko Inoue; Norio Matsuura; Amanda Helip-Wooley; Detlef Bockenhauer; Richard Warth; Isa Bernardini; Gepke Visser; Thomas Eggermann; Philip Lee; Arthit Chairoungdua; Promsuk Jutabha; Ellappan Babu; Sirinun Nilwarangkoon; Naohiko Anzai; Yoshikatsu Kanai; Francois Verrey; William A Gahl; Akio Koizumi
Journal:  Nat Genet       Date:  2004-08-01       Impact factor: 38.330

8.  The genetics of fibromuscular dysplasia.

Authors:  A R Rushton
Journal:  Arch Intern Med       Date:  1980-02

9.  Blood pressure screening, management and control in England: results from the health survey for England 1994.

Authors:  H M Colhoun; W Dong; N R Poulter
Journal:  J Hypertens       Date:  1998-06       Impact factor: 4.844

Review 10.  Fibromuscular dysplasia.

Authors:  Pierre-François Plouin; Jérôme Perdu; Agnès La Batide-Alanore; Pierre Boutouyrie; Anne-Paule Gimenez-Roqueplo; Xavier Jeunemaitre
Journal:  Orphanet J Rare Dis       Date:  2007-06-07       Impact factor: 4.123

View more
  3 in total

Review 1.  Renovascular hypertension--is it fibromuscular dysplasia or Takayasu arteritis.

Authors:  Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2012-03-28       Impact factor: 3.714

Review 2.  Genomics of Fibromuscular Dysplasia.

Authors:  Silvia Di Monaco; Adrien Georges; Jean-Philippe Lengelé; Miikka Vikkula; Alexandre Persu
Journal:  Int J Mol Sci       Date:  2018-05-21       Impact factor: 5.923

Review 3.  An Outline of Renal Artery Stenosis Pathophysiology-A Narrative Review.

Authors:  Lukasz Dobrek
Journal:  Life (Basel)       Date:  2021-03-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.